Veracyte | VCYT - Despesa De Juros Sobre A Dívida

Preço das Ações
34.33
Mudança Diária
1.18 3.56%
Mensal
4.70%
Anual
6.52%
Q2 Previsão
33.60




Despesa De Juros Sobre A Dívida Alterar Data
Agenus USD 16.02M 2.85M 2025-12
Agilent USD 25M 2M 2025-12
Anika Therapeutics 189.44M 1.76M 2025-09
Arrowhead Research USD 22.5M 811K 2025-12
Bruker USD 20M 4.3M 2025-09
Heron Therapeutics USD 600K 100K 2024-12
Illumina USD 25M 0 2025-09
Intrexon USD 2K 5K 2024-06
Karyopharm Therapeutics USD 12.62M 1.24M 2025-12
Laboratory Of America USD 55M 1000K 2025-12
Ligand Pharmaceuticals USD 910K 243K 2025-09
Myriad Genetics USD 4.4M 600K 2025-12
Rigel Pharmaceuticals USD 2.06M 31K 2024-09
Roche Holding CHF 304M 7.5M 2025-06
Sangamo BioSciences 97.56M 11.39M 2025-06
Siemens EUR 435M 1000K 2025-12
Sonic Healthcare AUD 86.91M 43.94M 2024-12
Thermo Fisher Scientific USD 354M 11M 2026-03
Veracyte USD 2K 1000 2023-12
Waters USD 8.62M 18.02M 2025-12